Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)

NCT04702503 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Interventions

DRUG: WP1220

Sponsor

Moleculin Biotech, Inc.